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University grant Program – Final report 
 
Name: Celine A Beamer, Ph.D. 
 
Department: Biomedical & Pharmaceutical Sciences 
 
Project Title: Establishment of immortalized innate lymphoid cell lines from the mouse lung. 
 
Objective: The purpose of this proposal was to create immortalized innate lymphoid cell (ILC) lines from 
normal and transgenic mice.  
 
Summary of Results: Although very rare, type 2 innate lymphoid cells are recognized as important 
players in the lungs during inflammation caused by ozone, allergens, and viruses.  Because the life span of 
primary ILCs in culture is limited and isolation techniques are expensive, time consuming, and labor 
intensive, it is highly desirable to create an immortalized cell line. Due to the limited funds available for 
this endeavor, we were only able to make one attempt to create an immortalized type 2 ILC cell line from 
the mouse lung. We chose to use a commercially available simian virus 40 (SV40) T antigen pre-packaged 
into ready-to-use lentivirus (Applied Biological Materials Inc., Richmond BC). Although we were able to 
successfully isolate type 2 ILCs form the lungs of naïve wild-type mice several times, the comprehensive 
set of conditions required for the generation of an immortalized cell line were not completed.  We 
experienced problems with bacterial contamination from the sorting process, toxicity of reagents, and 
incomplete infection of our primary cells.  Additional studies are ongoing in the laboratory to continue to 
develop this powerful tool. 
 
Extramural funding: At the present time, the preliminary data gathered have been used for 
methodological development only; although if successful, we expect that this tool will be incorporated 
into my current CBSD CoBRE subproject and R-type grant applications to the NIH. 
  
